1 |
Hydroxychloroquine |
Hydroxychloroquine |
[1] D08050 D08050 💬 |
- |
- |
013 [23] 13, 34, 41, 43, 44, 45, 46, 48, 49, 53, 56, 66, 84, 89, 90, 96, 218, 222, 234, 254, 271, 298, 299 💬 |
2 |
Hydroxychloroquine (z0188) |
Hydroxychloroquine |
[1] D08050 D08050 💬 |
- |
- |
049 [1] 49 💬 |
3 |
Hydroxychloroquine + prednisone |
Hydroxychloroquine |
[2] D00473 D00473, D08050 D08050 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
084 [1] 84 💬 |
4 |
Hydroxychloroquine high |
Hydroxychloroquine |
[1] D08050 D08050 💬 |
- |
- |
049 [1] 49 💬 |
5 |
Hydroxychloroquine higher dose |
Hydroxychloroquine |
[1] D08050 D08050 💬 |
- |
- |
090 [1] 90 💬 |
6 |
Hydroxychloroquine lower dose |
Hydroxychloroquine |
[1] D08050 D08050 💬 |
- |
- |
090 [1] 90 💬 |
7 |
Hydroxychloroquine or chloroquine |
Chloroquine |
[4] D02125 D02125, D02366 D02366, D03469 D03469, D08050 D08050 💬 |
- |
- |
049 [1] 49 💬 |
8 |
Hydroxychloroquine reduced |
Hydroxychloroquine |
[1] D08050 D08050 💬 |
- |
- |
049 [1] 49 💬 |
9 |
Hydroxychloroquine sulfate |
Hydroxychloroquine |
[1] D08050 D08050 💬 |
- |
- |
046 [2] 46, 66 💬 |
10 |
Hydroxychloroquine sulphate |
Hydroxychloroquine |
[1] D08050 D08050 💬 |
- |
- |
096 [1] 96 💬 |
11 |
Leflunomide-sulfasalazine-hydroxychloroquine |
Hydroxychloroquine |
[3] D00448 D00448, D00749 D00749, D08050 D08050 💬 |
DHODH [1] DHODH 💬 |
Biosynthesis of cofactors [3] Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism |
046 [1] 46 💬 |
12 |
Methotrexate + salazopyrine + hydroxychloroquine administration |
Hydroxychloroquine |
[3] D00142 D00142, D02115 D02115, D08050 D08050 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 [1] 46 💬 |
13 |
Methotrexate-sulfasalazine-hydroxychloroquine |
Hydroxychloroquine |
[4] D00142 D00142, D00448 D00448, D02115 D02115, D08050 D08050 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 [1] 46 💬 |
14 |
Other: hydroxychloroquine/chloroquine |
Chloroquine |
[4] D02125 D02125, D02366 D02366, D03469 D03469, D08050 D08050 💬 |
- |
- |
046 [1] 46 💬 |
15 |
Plaquenil - hydroxychloroquine 200mg film coated tablets |
Hydroxychloroquine |
[1] D08050 D08050 💬 |
- |
- |
043 [3] 43, 44, 45 💬 |
16 |
Sirolimus and hydroxychloroquine 200 mg |
Hydroxychloroquine |
[2] D00753 D00753, D08050 D08050 💬 |
MTOR [1] MTOR 💬 |
AMPK signaling pathway [50] AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway |
089 [1] 89 💬 |
17 |
Sirolimus and hydroxychloroquine 400 mg |
Hydroxychloroquine |
[2] D00753 D00753, D08050 D08050 💬 |
MTOR [1] MTOR 💬 |
AMPK signaling pathway [50] AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway |
089 [1] 89 💬 |
18 |
Sulphasalazine + hydroxychloroquine or prednisolone |
Hydroxychloroquine |
[9] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301, D08050 D08050 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
046 [1] 46 💬 |
19 |
Versus hydroxychloroquine |
Hydroxychloroquine |
[1] D08050 D08050 💬 |
- |
- |
049 [1] 49 💬 |